Tirilazad Mesylate Increases Dopaminergic Neuronal Survival in thein OculoGrafting Model
- 30 November 1997
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 148 (1), 324-333
- https://doi.org/10.1006/exnr.1997.6655
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral graftsNeuroReport, 1996
- GDNF reduces apoptosis in dopaminergic neurons in vitroNeuroReport, 1995
- LazaroidsDrugs, 1995
- Effects of Glial Cell Line-Derived Neurotrophic Factor on Developing and Mature Ventral Mesencephalic Grafts in OculoExperimental Neurology, 1995
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic NeuronsScience, 1993
- Effect of U74006F on Neurologic Function and Brain Edema After Fluid Percussion Injury in RatsJournal of Neurotrauma, 1993
- The Novel 21-Aminosteroid U74006F Attenuates Cerebral Edema and Improves Survival after Brain Injury in the RatJournal of Neurotrauma, 1992
- Dopamine neuron transplants: Electrophysiological unit activity of intrastriatal nigral grafts in freely moving catsLife Sciences, 1987
- Human fetal substantia nigra grafted to the dopamine-denervated striatum of immunosuppressed rats: evidence for functional reinnervationNeuroscience Letters, 1986